CGX-1321
- Generic Name
- CGX-1321
- Drug Type
- Small Molecule
Overview
CGX-1321 is a porcupine inhibitor that affects Wnt production and can block Wnt downstream signaling.
Background
CGX-1321 is a porcupine inhibitor that affects Wnt production and can block Wnt downstream signaling.
Indication
No indication information available.
Associated Conditions
No associated conditions information available.
Clinical Trials
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath